当前位置:首页 - 行情中心 - 特宝生物(688278) - 财务分析 - 现金流量表

特宝生物

(688278)

  

流通市值:259.20亿  总市值:259.20亿
流通股本:4.08亿   总股本:4.08亿

现金流量表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,370,745,401.212,454,222,650.871,609,290,713.9806,382,960.16
  收到的税费返还1,053,779.861,053,779.861.4-
  收到其他与经营活动有关的现金39,063,145.2830,954,046.7520,440,741.7814,936,533.5
  经营活动现金流入小计3,410,862,326.352,486,230,477.481,629,731,457.08821,319,493.66
  购买商品、接受劳务支付的现金273,886,111.15186,343,062.4188,983,339.7737,915,914.43
  支付给职工以及为职工支付的现金947,436,617.8686,802,192.98450,478,475.84251,792,654.35
  支付的各项税费263,713,378.45191,176,718.99142,204,355.1871,759,296.32
  支付其他与经营活动有关的现金1,196,450,350.09950,790,296.4587,519,873.82253,111,450.76
  经营活动现金流出小计2,681,486,457.492,015,112,270.781,269,186,044.61614,579,315.86
  经营活动产生的现金流量净额729,375,868.86471,118,206.7360,545,412.47206,740,177.8
二、投资活动产生的现金流量:
  收回投资收到的现金1,559,427,565.981,047,638,167.17846,874,667.36581,340,103.53
  处置固定资产、无形资产和其他长期资产收回的现金净额745,790.5321,90021,30014,000
  投资活动现金流入小计1,560,173,356.511,047,660,067.17846,895,967.36581,354,103.53
  购建固定资产、无形资产和其他长期资产支付的现金256,143,258.1168,636,047.1998,678,266.4459,717,400.69
  投资支付的现金1,745,966,623.841,178,394,721.08695,000,000570,000,000
  取得子公司及其他营业单位支付的现金58,394,721.08---
  投资活动现金流出小计2,060,504,603.021,347,030,768.27793,678,266.44629,717,400.69
  投资活动产生的现金流量净额-500,331,246.51-299,370,701.153,217,700.92-48,363,297.16
三、筹资活动产生的现金流量:
  吸收投资收到的现金54,439,826.454,439,826.4--
  取得借款收到的现金140,670,352.2120,000,00010,000,00010,000,000
  筹资活动现金流入小计195,110,178.6174,439,826.410,000,00010,000,000
  分配股利、利润或偿付利息支付的现金252,874,306.73252,387,208.33252,362,208.33146,208.33
  支付其他与筹资活动有关的现金9,393,732.255,970,558.544,420,102.392,044,881.9
  筹资活动现金流出小计262,268,038.98258,357,766.87256,782,310.722,191,090.23
  筹资活动产生的现金流量净额-67,157,860.38-83,917,940.47-246,782,310.727,808,909.77
四、汇率变动对现金及现金等价物的影响-549,425.9-201,057.26170,763.6364,915.87
五、现金及现金等价物净增加额161,337,336.0787,628,507.87167,151,566.3166,250,706.28
  加:期初现金及现金等价物余额361,515,698.43361,515,698.43361,515,698.43361,515,698.43
  期末现金及现金等价物余额522,853,034.5449,144,206.3528,667,264.73527,766,404.71
补充资料:
  净利润1,031,236,252.58-427,894,111.21-
  固定资产和投资性房地产折旧67,097,292.45-23,156,309.38-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧67,097,292.45-23,156,309.38-
  无形资产摊销49,189,014.34-20,423,225.35-
  长期待摊费用摊销21,405,483.71-6,166,068.79-
  处置固定资产、无形资产和其他长期资产的损失718,026.13--21,300-
  固定资产报废损失269,228.25-242,604.15-
  公允价值变动损失-3,448,015.83--590,535.23-
  财务费用1,971,417.52-209,203.06-
  投资损失-6,599,263.41--1,873,297.19-
  递延所得税-21,659,765.43--3,070,583.72-
  其中:递延所得税资产减少-28,422,780.7--3,121,936.16-
    递延所得税负债增加6,763,015.27-51,352.44-
  存货的减少-164,064,868.87--57,645,754.59-
  经营性应收项目的减少-405,579,582.89-4,504,566.2-
  经营性应付项目的增加88,480,145.44--87,684,247.3-
  其他61,855,511.2-26,392,458.89-
  现金的期末余额522,853,034.5-528,667,264.73-
  减:现金的期初余额361,515,698.43-361,515,698.43-
  现金及现金等价物的净增加额161,337,336.07-167,151,566.3-
公告日期2026-03-272025-10-232025-08-212025-04-23
审计意见(境内)标准无保留意见
TOP↑